pyrrolidonecarboxylic acid has been researched along with Dyskinesia Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lekic, T; Manaenko, A; Tang, J; Zhang, JH | 1 |
| Boschi, G; Launay, N; Rips, R | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Dyskinesia Syndromes
| Article | Year |
|---|---|
NC1900, an arginine vasopressin analogue, fails to reduce brain edema and improve neurobehavioral deficits in an intracerebral hemorrhagic stroke mice model.
Topics: Analysis of Variance; Animals; Aquaporin 4; Arginine Vasopressin; Basal Ganglia; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gait Disorders, Neurologic; Male; Mice; Movement Disorders; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors | 2011 |
Induction of wet-dog shakes by intracerebral 'acid' TRH in rats.
Topics: Animals; Apomorphine; Cyproheptadine; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Male; Movement Disorders; Naloxone; Phentolamine; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1980 |